Comprehensive Lung Cancer Diagnostic And Screening Market Forecast 2025-2034: Growth Trends and Strategic Shifts

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Lung Cancer Diagnostic And Screening Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the last few years, the lung cancer diagnostic and screening market has seen substantial growth. It is projected to increase from $2.34 billion in 2024 to $2.56 billion in 2025, at a compound annual growth rate (CAGR) of 9.6%. Factors contributing to the historical growth include the improvement in digital imaging, standardization of screening methods, public health campaigns against tobacco consumption, creation of cancer databases, and progress in the area of pathology analysis.

Lung Cancer Diagnostic And Screening Market Size Forecast: What's the Projected Valuation by 2029?
Expectations indicate robust expansion for the lung cancer diagnostic and screening market in the approaching years. The market is projected to reach $3.69 billion by 2029, with a compound annual growth rate (CAGR) of 9.5%. This anticipated growth can be attributed to factors such as increased instances of lung cancer, heightened focus on early detection, the spread of high-risk screening methods, a shift towards personalized medicine, and governmental support and funding. The forecast period hints at significant trends like the springing up of innovative screening methods, progress in biomarker testing, incorporation of artificial intelligence (AI), a surge in the adoption of liquid biopsy, emphasis on early-stage detection, and broadening of low-dose CT screening programs.

View the full report here:
https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

What Are the Drivers Transforming the Lung Cancer Diagnostic And Screening Market?
The escalating rates of lung cancer are anticipated to spur the expansion of the lung cancer diagnostic and screening market. This deadly disease, characterized by the unchecked multiplication of abnormal cells in the lung tissues, manifests symptoms like coughing, chest pain, and breathing difficulties. Early detection of the disease in lung cancer patients is facilitated by lung cancer diagnosis and screening, employing tests such as incisional biopsy and bronchoscopy. For instance, the American Cancer Society, a US-based government organization, reported in January 2023 that the United States witnessed approximately 238,340 new lung cancer cases (117,550 in men and 120,790 in women). Additionally, there were about 127,070 lung cancer-related deaths (67,160 in men and 59,910 in women). Consequently, the escalating prevalence of lung cancer is fuelling the expansion of the lung cancer diagnostic and screening market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12043&type=smp

What Long-Term Trends Will Define the Future of the Lung Cancer Diagnostic And Screening Market?
Leading firms in the lung cancer diagnostic and screening market are innovating technologies like lung cancer examinations to promote early detection, increase diagnostic precision, and encourage tailored treatment strategies for high-risk patients. Lung cancer examinations are diagnostic methods designed to identify lung cancer presence via several techniques, including imaging, biomarker evaluation, and cytological tests. For example, Freenome, a biotech company based in the US, introduced PROACT LUNG in December 2023. The PROACT LUNG experiment marks a hopeful move towards transforming lung cancer screening, potentially leading to quicker detection and improved patient outcomes while tackling current gaps in existing screening practices.

Which Segments in the Lung Cancer Diagnostic And Screening Market Offer the Most Profit Potential?
The lung cancer diagnostic and screening market covered in this report is segmented -

1) By Product: Instruments, Consumables And Accessories
2) By Test: Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests
3) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer
4) By End User: Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users

Subsegments:
1) By Instruments: Imaging Devices, Biopsy Devices, Bronchoscopy Systems
2) By Consumables And Accessories: Biopsy Needles, Reagents And Assays, Imaging Contrast Agents, Patient Preparation Equipment, Sample Collection Kits, Laboratory Supplies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12043&type=smp

Which Firms Dominate the Lung Cancer Diagnostic And Screening Market by Market Share and Revenue in 2025?
Major companies operating in the lung cancer diagnostic and screening market include Pfizer Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories Inc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetic Laboratories Inc., NeoGenomics Laboratories Inc., Canon Medical Systems Corporation, OncimmuneHoldings Plc, Broncus Medical Inc., OncoCyte, Riverain Technologies LLC, VisionGate, Foundation Medicine Inc., Biodesix,

Which Regions Offer the Highest Growth Potential in the Lung Cancer Diagnostic And Screening Market?
North America was the largest region in the lung cancer diagnostic and screening market in 2024. The regions covered in the lung cancer diagnostic and screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12043

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.